文献速递中医内科中药与中成药合理使用

线粒体与内质网交互在缺血性心肌损伤中的作用及天然药物靶向

Decoding interaction between mitochondria and endoplasmic reticulum in ischemic myocardial injury: targeting natural medicines.
PubMed 文献 · Front Pharmacol · 2025-02-28

本文综述缺血性心肌病中炎症与氧化应激交互触发冠状动脉微血管损伤的机制,指出内质网功能失衡与线粒体质量控制异常是重要驱动因素,并总结中药及其天然单体成分通过线粒体质量控制和内质网保护改善血管内皮功能、减轻血管损伤的治疗作用。

要点

  • 炎症与氧化应激交互触发细胞死亡,是冠脉微血管损伤的关键机制。
  • 内质网功能失衡与线粒体质量控制异常驱动炎症和氧化应激。
  • 中药及天然单体成分可通过线粒体与内质网保护机制减轻血管损伤。

核心结论

  • 缺血性心肌病中炎症与氧化应激交互触发细胞死亡,导致冠状动脉微血管损伤。
  • 内质网功能失衡与线粒体质量控制异常是炎症和氧化应激的重要潜在驱动因素。
  • 中药及其天然单体成分可通过线粒体质量控制和内质网保护机制改善血管内皮功能、减轻血管损伤。

研究设计与样本

  • 综述,检索范围未在摘要中报告。

主要发现

  • 炎症与氧化应激交互作用触发细胞死亡,是冠状动脉微血管损伤的原因。
  • 内质网功能失衡与线粒体质量控制异常是炎症和氧化应激的重要潜在驱动因素。
  • 多项研究证实中药及天然单体成分对血管损伤具有治疗作用。

临床怎么用

  • 关注缺血性心肌病中炎症与氧化应激交互导致的冠状动脉微血管损伤。
  • 重视内质网功能与线粒体质量控制在心肌缺血损伤中的潜在驱动作用。
  • 中药及天然单体成分可作为针对冠状动脉微血管损伤的潜在治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ischemic cardiomyopathy (ICM) is a special type or end stage of coronary heart disease or other irreversible ischemic myocardial injury. Inflammatory damage to coronary vessels is a crucial factor in causing stenosis or occlusion of coronary arteries, resulting in myocardial ischemia and hypoxia, but it is also an aspect of cardioprotection that is often overlooked. This review discusses the mechanisms of vascular injury during ICM, in which inflammation and oxidative stress interact and trigger cell death as the cause of coronary microvascular injury. Imbalances in endoplasmic reticulum function and mitochondrial quality control are important potential drivers of inflammation and oxidative stress. In addition, many studies have confirmed the therapeutic effects of Chinese herbal medicines and their natural monomeric components on vascular injuries. Their mitochondrial quality control and endoplasmic reticulum protection mechanisms as well as their role in combating improvements in vascular endothelial function and attenuating vascular injury are also summarized, with a perspective to provide a reference for pathologic understanding, drug research, and clinical application of ICM-associated coronary microvascular injury.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang C, Chang X, Zhao D, et al. Decoding interaction between mitochondria and endoplasmic reticulum in ischemic myocardial injury: targeting natural medicines. Front Pharmacol. 2025. PMID: 40093324. doi:10.3389/fphar.2025.1536773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。